During the past decade, Encore Medical Research conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 8 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 8 clinical trials were completed. i.e. 47.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Encore Medical Research" #1 sponsor was "Eli Lilly and Company" with 10 trials, followed by "Andover Eye Associates" with 1 trials sponsored, "Aristea Therapeutics, Inc." with 1 trials sponsored, "Evofem Inc." with 1 trials sponsored and "Galapagos NV" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Encore Medical Research" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator, "AbCellera Biologics Inc." with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Regeneron Pharmaceuticals" with 1 trials as a collaborator and "Shanghai Junshi Bioscience Co., Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Encore Medical Research" are "Type 2 Diabetes" (4 trials), "Atopic Dermatitis" (3 trials), "COVID-19" (2 trials), "Covid19" (2 trials) and "Type 2 Diabetes Mellitus" (2 trials). Many other conditions were trialed in "Encore Medical Research" in a lesser frequency.

Most popular intervention types in "Encore Medical Research" are "Drug" (16 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Dulaglutide" (2 trials), "Insulin Efsitora Alfa" (2 trials), "LY3437943" (2 trials) and "Lebrikizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Encore Medical Research" are 17 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Encore Medical Research". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 7 completed trials in Encore Medical Research, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Encore Medical Research, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".